Wilson Sonsini advised Misfits Market on the deal. Misfits Market, the online grocery platform driven by accessibility, affordability, and sustainability, announced the acquisition of online grocer...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Lunar Energy on the deal. Lunar Energy, a California-based start-up dedicated to delivering home electrification, emerged from stealth mode having successfully raised over...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised PolyAI on the deal. PolyAI, a leading provider of enterprise voice assistants, raised $40 million in a Series B funding...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Harmonic Discovery on the deal. Harmonic Discovery, a therapeutics company building an integrated computational and experimental platform for kinase drug...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Grid Dynamics on the deal. Grid Dynamics, a leader in enterprise-level digital transformation, announced the pricing of an underwritten public offering of 5,714,286...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advises Rambus Inc. on the deal. Rambus Inc., a provider of industry-leading chips and silicon IP making data faster and safer, announced that it...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Good Therapeutics on the deal. Good Therapeutics, a privately held company founded to create a new class of conditionally active therapeutics, announced it...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised RayzeBio on the deal. RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced a $160 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Lefosse advised Conexa Saúde on the deal, while Mattos Filho advised Goldman Sachs. Conexa Saúde, a leader in telemedicine in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Marengo on the deal. Ipsen and Marengo Therapeutics announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised AliveCor on the deal. AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced its Series F Financing led by GE Healthcare....
You must be a Standard 1 Year member to access this content.
